International Stem Cell Corporation
ISCO
$0.14
-$0.03-15.15%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.19% | 14.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.19% | 14.94% | |||
| Cost of Revenue | 13.05% | -6.55% | |||
| Gross Profit | -13.09% | 33.69% | |||
| SG&A Expenses | -10.24% | 2.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.22% | -2.73% | |||
| Operating Income | -43.71% | 177.67% | |||
| Income Before Tax | -55.81% | 150.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -55.81% | 150.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.81% | 150.39% | |||
| EBIT | -43.71% | 177.67% | |||
| EBITDA | -32.13% | 238.13% | |||
| EPS Basic | -57.14% | 126.25% | |||
| Normalized Basic EPS | -55.45% | 150.50% | |||
| EPS Diluted | -57.14% | 126.25% | |||
| Normalized Diluted EPS | -56.44% | 150.50% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.04% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||